tiprankstipranks
Trending News
More News >
CAMP4 Therapeutics: Promising Pipeline and Strong Financials Justify Buy Rating
PremiumRatingsCAMP4 Therapeutics: Promising Pipeline and Strong Financials Justify Buy Rating
2M ago
Camp4 Therapeutics  reports Q1 EPS (62c), consensus (70c)
Premium
The Fly
Camp4 Therapeutics reports Q1 EPS (62c), consensus (70c)
2M ago
CAMP4 Therapeutics Advances RNA-Based Therapeutics
Premium
Company Announcements
CAMP4 Therapeutics Advances RNA-Based Therapeutics
3M ago
Camp4 Therapeutics appoints Maraganore, Meyers are strategic advisors
PremiumThe FlyCamp4 Therapeutics appoints Maraganore, Meyers are strategic advisors
7M ago
CAMP4 Therapeutics Corp trading resumes
Premium
The Fly
CAMP4 Therapeutics Corp trading resumes
7M ago
CAMP4 Therapeutics Corp trading halted, volatility trading pause
Premium
The Fly
CAMP4 Therapeutics Corp trading halted, volatility trading pause
7M ago
Camp4 Therapeutics initiated with an Overweight at Piper Sandler
PremiumThe FlyCamp4 Therapeutics initiated with an Overweight at Piper Sandler
8M ago
Opening Day: Polyrizon, Gelteq debut in quiet IPO week
Premium
The Fly
Opening Day: Polyrizon, Gelteq debut in quiet IPO week
8M ago
Four new option listings and one option delisting on June 12th
Premium
The Fly
Four new option listings and one option delisting on June 12th
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100